C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early- and long-term mortality.

Abstract

Patient selection for allogeneic haematopoietic cell transplantation (HCT) is complex and outcome can be predicted by the HCT comorbidity index (HCT-CI) (Sorror et al, 2005) or the European Group for Blood and Marrow Transplantation (EBMT) score (Gratwohl et al, 1998; Gratwohl, 2012). HCTCI accounts for patient factors such as proven or suspected recipient… (More)
DOI: 10.1111/bjh.14454

Topics

2 Figures and Tables

Cite this paper

@article{Patel2016CreactivePP, title={C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early- and long-term mortality.}, author={Amit Patel and Richard M. Szydlo and Holger Werner Auner and Edward J Kanfer and Donald H C Macdonald and Dragana Milojkovic and Syed Khalid Altaf and Andrew Innes and I. Gabriel and Amin Rahemtulla and Aristeidis I Chaidos and Anastasios Karadimitris and Eduardo Olavarr{\'i}a and Jane F. Apperley and Jiř{\'i} Pavlů}, journal={British journal of haematology}, year={2016} }